EDNRB and vitiligo: As shown in Table 3 and Fig. 2g, we found that the gene expression patterns of multiple drugs were significantly correlated with the down-regulated gene expression patterns in vitiligo patients, where rosiglitazone may increase melanogenesis by activating the EDNRB gene.